Capsule Intelligence Station | Breathing In a Greener Future: Plant-Based Empty Capsules for Dry Powder Inhalation — Sustainability, Dual-Carbon Goals and Industry Outlook

Under the national advocacy of the "Dual Carbon" strategy and the high-quality development of the pharmaceutical industry, green, sustainable, and high-quality transformation has become a consensus of the pharmaceutical industrial era. Every innovation in tiny pharmaceutical excipients is quietly driving a greener, healthier future.

Today, we turn our attention to the "golden track" of respiratory diseases (such as COPD and asthma) — Dry Powder Inhalers (DPI). In this high-end formulation technology that delivers fine powder directly to lung lesions, the capsule shell that carries the drug is undergoing a green industrial revolution, shifting from "animal-derived gelatin" to "🍃 green plant-derived HPMC (hydroxypropyl methylcellulose)."

From "Animal Source" to "Green Plant" — Sustainable Transformation of Pharmaceutical Excipients

For a long time, traditional medicinal empty capsules have mostly used gelatin extracted from animal bones or skin as raw material. However, under the macro trend of sustainable development and "carbon neutrality," animal-derived excipients face limitations such as high carbon footprint, large resource consumption, and potential risks of animal-derived diseases.

The emergence of plant-derived HPMC (hydroxypropyl methylcellulose) empty capsules has opened up a green, low-carbon path for the industry:

👉 Renewable and sustainable

Plant-grade HPMC is derived from natural, renewable lignocellulose. Its entire production life cycle is more in line with green chemistry principles, greatly reducing dependence on traditional livestock by-products, making it a veritable "low-carbon excipient."

👉 Natural safety attributes

Plant capsules do not contain animal protein, which not only avoids application barriers for religious and vegetarian groups, but also completely eliminates the physical risk of cross-species virus transmission such as mad cow disease, providing a more uniform and safer green choice for global patients.

1-Micron Hardcore Technology — Plant Capsules Overcome Pain Points of Inhalation Preparations

In dry powder inhalers (DPI), the capsule is not just packaging; it is a "temporary precision drug delivery device" that cooperates with the inhalation device to release powder through needle piercing and high-speed rotation. This unique clinical application scenario imposes extremely stringent requirements on the physical limits of materials. Plant capsules are the breakthrough that overcomes the technical pain points of traditional gelatin capsules:

👉 "Zero-fragment" safety breakthrough in extremely dry environments

The powder of dry powder inhalers is extremely sensitive to moisture, requiring relative humidity in production and packaging environments to be controlled below 30%. Traditional gelatin capsules become brittle due to dehydration in such extremely dry environments, and are prone to shattering and producing hard debris during needle piercing, risking accidental inhalation by patients into the respiratory tract. Plant HPMC capsules adopt a gelling-agent-free thermal gelation film-forming process, maintaining extremely high physical toughness at a very low equilibrium moisture of 3.0% to 6.0%. During needle piercing, they achieve "precise punching and smooth cuts," completely eliminating the hidden danger of fragments.

👉 No cross-linking reaction, more stable drug efficacy

Gelatin is rich in amino acids, making it highly prone to cross-linking reactions with trace amounts of drugs, leading to capsule insolubility. Plant-derived HPMC is chemically inert and has no risk of interaction with various small-molecule drugs and bioactive ingredients, ensuring the release stability of inhalation preparations during their shelf life.

Continuously Focusing on the Frontier — Empowering Industrial Heights with Green Excipients

As explorers who have always been deeply engaged in the field of plant-based pharmaceutical excipients, we closely track global cutting-edge material chemistry and green pharmaceutical technology. From internationally advanced formulation pipelines (such as glycopyrronium bromide inhalation powder), it can be seen that low-hydration, high-puncture-toughness plant HPMC capsules have gradually replaced gelatin and become the mainstream shell material choice for global high-end inhalation preparations.

We firmly believe that "plant replacing animal" and "sustainable green excipients" are the only way for the pharmaceutical industry to achieve high quality and dual-carbon goals.

In the future, we will continue to uphold the development philosophy of green, environmental protection, and innovation, walking side by side with the country, industry peers, and customers, and continuously deepen R&D and technical accumulation in plant-based pharmaceutical excipients. With the micro-nano power of green technology, we safeguard every free breath of humanity.